ArticleNeurocomputing2022
Effective multiscale deep learning model for COVID19 segmentation tasks: A further step towards helping radiologist.
Article in Neurocomputing, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed, 5 citations in OpenAlex.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Infection by the SARS-CoV-2 leading to COVID-19 disease is still rising and techniques to either diagnose or evaluate the disease are still thoroughly investigated. The use of CT as a complementary tool to other biological tests is still under scrutiny as the CT scans are prone to many false positives as other lung diseases display similar characteristics on CT scans. However, fully investigating CT images is of tremendous interest to better understand the disease progression and therefore thousands of scans need to be segmented by radiologists to study infected areas. Over the last year, many deep learning models for segmenting CT-lungs were developed. Unfortunately, the lack of large and shared annotated multicentric datasets led to models that were either under-tested (small dataset) or not properly compared (own metrics, none shared dataset), often leading to poor generalization performance. To address, these issues, we developed a model that uses a multiscale and multilevel feature extraction strategy for COVID19 segmentation and extensively validated it on several datasets to assess its generalization capability for other segmentation tasks on similar organs. The proposed model uses a novel encoder and decoder with a proposed kernel-based atrous spatial pyramid pooling module that is used at the bottom of the model to extract small features with a multistage skip connection concatenation approach. The results proved that our proposed model could be applied on a small-scale dataset and still produce generalizable performances on other segmentation tasks. The proposed model produced an efficient Dice score of 90% on a 100 cases dataset, 95% on the NSCLC dataset, 88.49% on the COVID19 dataset, and 97.33 on the StructSeg 2019 dataset as compared to existing state-of-the-art models. The proposed solution could be used for COVID19 segmentation in clinic applications. The source code is publicly available at https://github.com/RespectKnowledge/Mutiscale-based-Covid-_segmentation-usingDeep-Learning-models.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.